Icarus Medical secures $7.2M Series A to accelerate growth and innovation

Icarus Medical has secured an oversubscribed $7.2 million Series A financing round to accelerate commercialization and development of its orthopedic bracing technologies. The Charlottesville-based medtech company develops advanced braces using biomechanics, additive manufacturing, and patient-focused...

Icarus Medical secures $7.2M Series A to accelerate growth and innovation

Icarus Medical has secured an oversubscribed $7.2 million Series A financing round to accelerate commercialization and development of its orthopedic bracing technologies. The Charlottesville-based medtech...

Wise closes $34.8M Series D to support neurostim tech

Italian medtech company WISE has closed an oversubscribed €30 million ($34.8 million) Series D financing round to accelerate development and clinical adoption of its...

Cardiawave reports first Valvosoft treatments in Europe

Cardiawave has announced the first patients treated in Europe with its Valvosoft platform, following the system’s CE mark approval for severe symptomatic aortic stenosis...

Distalmotion gets FDA nod to expand Dexter surgical robot indications to gynecology

Distalmotion has received FDA 510(k) clearance to expand the use of its Dexter surgical robot across additional gynecologic procedures, including sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and...
[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Innovation

Regulatory Approvals

Icarus Medical secures $7.2M Series A to accelerate growth and innovation

Icarus Medical has secured an oversubscribed $7.2 million Series A financing round to accelerate commercialization and development of its orthopedic bracing technologies. The Charlottesville-based medtech...

Wise closes $34.8M Series D to support neurostim tech

Italian medtech company WISE has closed an oversubscribed €30 million ($34.8 million) Series D financing round to accelerate development and clinical adoption of its...

Cardiawave reports first Valvosoft treatments in Europe

Cardiawave has announced the first patients treated in Europe with its Valvosoft platform, following the system’s CE mark approval for severe symptomatic aortic stenosis...

Distalmotion gets FDA nod to expand Dexter surgical robot indications to gynecology

Distalmotion has received FDA 510(k) clearance to expand the use of its Dexter surgical robot across additional gynecologic procedures, including sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and...

M&A

Archives

Latest articles